Indian Firms Prepare to Develop Generic Versions of Keytruda as Patent Expiration Approaches
As the patent for Merck & Co’s Keytruda nears expiration, at least...
As the patent for Merck & Co’s Keytruda nears expiration, at least...
The Indian Union Budget for the 2026-27 fiscal year represents a transformative...
New Delhi — Institutions rooted in India’s traditional systems of medicine,...
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.